Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063906
Chunk: 47

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 47
---
 the Combined Company; •litigation that may be filed against Aptorum, DiamiR, Merger Sub and/or the members of Aptorum’s Board could prevent or delay the consummation of the Merger or result in the payment of damages following completion of the Merger; •the unaudited pro formacondensed combined financial information and prospective financial information included in this proxy statement/prospectus are presented for illustrative purposes only and the actual financial condition and results of operations of the Combined Company following the Merger may differ materially; 12 •Aptorum may waive one or more of the conditions to the Merger without resoliciting shareholder approval; •the Merger cannot be completed without the approval of the Domestication Proposal and the Nasdaq Stock Issuance Proposal; •Aptorum’s executive officers and directors have interests in the Merger that may be different from, or in addition to, the interests of Aptorum shareholders; •if Aptorum’s due diligence investigation of DiamiR was inadequate or if unexpected risks related to DiamiR’s business materialize, it could have a material adverse effect on the investment of Aptorum’s shareholders; •after the completion of the Merger, the Combined Company may fail to realize the anticipated benefits and cost savings of the Merger, which could adversely affect the value of the shares of Combined Company common stock following the Merger; •upon the completion of the Merger, Aptorum shareholders will have different rights under the Combined Company’s governing documents from those they currently have under Aptorum’s governing documents; •current Aptorum shareholders will have a reduced ownership and voting interest after the Merger and will exercise less influence over the management of the Combined Company; •the future results of the Combined Company may be adversely impacted if the Combined Company does not effectively manage its expanded operations following completion of the Merger; •each of Aptorum and DiamiR expects to incur substantial expenses related to the completion of the Merger and the integration of the businesses of Aptorum and DiamiR; and •the market price of shares of Combined Company common stock after the Merger may be affected by factors different from those that are currently affecting or historically have affected the market price of shares of Aptorum Class A ordinary shares. Consequently, all of the forward -lookingstatements Aptorum or DiamiR made in this document are qualified by the information contained in or incorporated by reference into this proxy statement/prospectus, including, but not limited to, (i) the information contained under this heading